ARCHIVES

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Group, Other Cancer Meetings for Oct., Nov., Future

September 29, 1989

Clinical Trials: Institutions Invited By NSABP To Join Raloxifene Trial

July 10, 1998

Research Teams Win Honors For Cancer Immunotherapy Work

October 15, 2010

House Committee To Examine Personal Genetic Test Kits

May 21, 2010

User Fees Proposed For FDA Oversight Services; Industry Groups Call It “Tax On Innovations”

January 20, 1989

Abortion, Miscarriage Don’t Increase Breast Cancer Risk, NCI Workshop Finds

March 7, 2003